ARTICLE | Clinical News
Daclizumab: Phase II data
May 31, 2004 7:00 AM UTC
In a U.S., open-label Phase II trial of 11 patients with relapsing-remitting or secondary progressive MS who failed treatment with interferon beta (IFN beta), the combination of IFN beta and daclizuma...